Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence - Implications for vaccine trial design

Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence - Implications for vaccine trial design

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Immunology - Volume 195, October 2018, Pages 28-35

Doreen O. Jackson, Francois A. Trappey, G. Travis Clifton, Timothy J. Vreeland, Kaitlin M. Peace, Diane F. Hale, Jennifer K. Litton, James L. Murray, Sonia A. Perez, Michael Papamichail, Elizabeth A. Mittendorf, George E. Peoples,